Product
RP-L102
2 clinical trials
1 indication
Indication
Fanconi AnemiaClinical trial
A Phase 2 Clinical Trial to Evaluate the Efficacy of the Infusion of Autologous CD34+ Cells Transduced With a Lentiviral Vector Carrying the FANCA Gene in Pediatric Subjects With Fanconi Anemia Subtype AStatus: Active (not recruiting), Estimated PCD: 2026-05-01
Clinical trial
A Phase II Clinical Trial to Evaluate the Efficacy of the Infusion of Autologous CD34+ Cells Transduced With a Lentiviral Vector Carrying the FANCA Gene (Orphan Drug) in Patients With Fanconi Anemia Subtype AStatus: Active (not recruiting), Estimated PCD: 2025-02-01